190 related articles for article (PubMed ID: 20620489)
21. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
Kaşifoğlu N; Us T; Akgün Y
Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis G virus infection in hemodialysis patients from urban Delhi.
Kumar D; Arora A; Singh NP; Kohli R; Kar P; Das BC
Ren Fail; 2005; 27(1):87-93. PubMed ID: 15717640
[TBL] [Abstract][Full Text] [Related]
24. [The relationship between viral load and malondialdehyde and antioxidant enzymes in patients with hepatitis C virus infection].
Kaya S; Sütüçü R; Sesli Cetin E; Cicioğlu Aridoğan B; Aktütrk O; Delibaş N
Mikrobiyol Bul; 2006; 40(1-2):55-61. PubMed ID: 16775957
[TBL] [Abstract][Full Text] [Related]
25. Oxidative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation.
Marotta F; Yoshida C; Barreto R; Naito Y; Packer L
J Gastroenterol Hepatol; 2007 May; 22(5):697-703. PubMed ID: 17444858
[TBL] [Abstract][Full Text] [Related]
26. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
27. Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients.
Akgul A; Bilgic A; Sezer S; Ozdemir FN; Olcay I; Arat Z; Haberal M
Hemodial Int; 2007 Apr; 11(2):198-203. PubMed ID: 17403171
[TBL] [Abstract][Full Text] [Related]
28. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
Minz M; Sharma A; Das A; Chawla Y
Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus infection in French hemodialysis units: a multicenter study.
Salama G; Rostaing L; Sandres K; Izopet J
J Med Virol; 2000 May; 61(1):44-51. PubMed ID: 10745231
[TBL] [Abstract][Full Text] [Related]
30. Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts.
Yelken B; Gorgulu N; Caliskan Y; Elitok A; Cimen AO; Yazici H; Oflaz H; Turkmen A; Sever MS
Transplant Proc; 2009 Jun; 41(5):1519-23. PubMed ID: 19545669
[TBL] [Abstract][Full Text] [Related]
31. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
[TBL] [Abstract][Full Text] [Related]
32. Is hepatitis C virus-RNA detection by nested polymerase chain reaction clinically relevant in hemodialysis patients?
Dussol B; de Lamballerie X; Brunet P; Roubicek C; Chicheportiche C; Cantaloube JF; Biagini P; de Micco P; Berland Y
Clin Nephrol; 1996 Apr; 45(4):257-60. PubMed ID: 8861802
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study.
Kalantar-Zadeh K; McAllister CJ; Miller LG
Nephrol Dial Transplant; 2005 Aug; 20(8):1662-9. PubMed ID: 15905194
[TBL] [Abstract][Full Text] [Related]
34. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution].
Bozdayi G; Rota S; Verdi H; Derici U; Sindel S; Bali M; Başay T
Mikrobiyol Bul; 2002; 36(3-4):291-300. PubMed ID: 12838663
[TBL] [Abstract][Full Text] [Related]
35. Gamma-glutamyltransferase activity in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection.
Souza JF; Longui CA; Miorin LA; Sens YA
Transplant Proc; 2008 Jun; 40(5):1319-23. PubMed ID: 18589096
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress markers in hepatitis C infected hemodialysis patients.
Köken T; Serteser M; Kahraman A; Gökçe C
J Nephrol; 2002; 15(3):302-7. PubMed ID: 12113603
[TBL] [Abstract][Full Text] [Related]
37. Additional effect of hyperparathyroidism on inflammatory status and rHuEPO requirements in hemodialysis patients.
Tutal E; Sezer S; Afsar B; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2006 Nov; 38(9):2807-12. PubMed ID: 17112835
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
[TBL] [Abstract][Full Text] [Related]
39. Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function.
Azevedo HA; Villela-Nogueira CA; Perez RM; Segadas-Soares JA; Takahashi C; Gaburo N; Pessoa I; Coelho HS
J Nephrol; 2007; 20(5):609-16. PubMed ID: 17918148
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress and thyroid hormones in patients with liver diseases.
Moustafa AH; Ali EM; Mohamed TM; Abdou HI
Eur J Intern Med; 2009 Nov; 20(7):703-8. PubMed ID: 19818291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
